Vis enkel innførsel

dc.contributor.authorRoer, Grethe Emilie
dc.contributor.authorLien, Lars
dc.contributor.authorBolstad, Ingeborg
dc.contributor.authorAaseth, Jan Olav
dc.contributor.authorAbebe, Dawit Shawel
dc.date.accessioned2024-02-23T14:46:19Z
dc.date.available2024-02-23T14:46:19Z
dc.date.created2023-05-24T13:07:51Z
dc.date.issued2023
dc.identifier.citationBMC Psychiatry. 2023, 23 (1), .en_US
dc.identifier.issn1471-244X
dc.identifier.urihttps://hdl.handle.net/11250/3119715
dc.description.abstractBackground: Posttraumatic stress disorder (PTSD) is associated with cardiometabolic diseases, concurrent anxiety, alcohol use disorder and depression. The relationship between PTSD and cardiometabolic diseases are still unclear, and less is known about the effects of socioeconomic status, comorbid anxiety, comorbid alcohol use disorder and comorbid depression. The study, therefore, aims to examine the risk of developing cardiometabolic diseases including type 2 diabetes mellitus over time in PTSD patients, and to what extent socioeconomic status, comorbid anxiety, comorbid alcohol use disorder and comorbid depression attenuate associations between PTSD and risk of developing cardiometabolic diseases. Method: A retrospective, register-based cohort study with 6-years follow-up of adult (> 18 years) PTSD patients (N = 7 852) compared with the general population (N = 4 041 366), was performed. Data were acquired from the Norwegian Patient Registry and Statistic Norway. Cox proportional regression models were applied to estimate hazard ratios (HRs) (99% confidence intervals) of cardiometabolic diseases among PTSD patients. Results: Significantly (p < 0.001) higher age and gender adjusted HRs were disclosed for all cardiometabolic diseases among PTSD patients compared to the population without PTSD, with a variation in HR from 3.5 (99% CI 3.1-3.9) for hypertensive diseases to HR = 6.5 (5.7-7.5) for obesity. When adjusted for socioeconomic status and comorbid mental disorders, reductions were observed, especially for comorbid depression, for which the adjustment resulted in HR reduction of about 48.6% for hypertensive diseases and 67.7% for obesity. Conclusions: PTSD was associated with increased risk of developing cardiometabolic diseases, though attenuated by socioeconomic status and comorbid mental disorders. Health care professionals should be attentive towards the burden and increased risk that low socioeconomic status and comorbid mental disorders may represent for PTSD patients' cardiometabolic health. Keywords: Alcohol use disorder; Cardiovascular diseases; Cohort study; Comorbidity; Depression; Diabetes mellitus; Epidemiology; Metabolic diseases; Posttraumatic stress disorder; Register data. © 2023. The Author(s).en_US
dc.description.sponsorshipThis research were funded by Innlandet Hospital Trust through the research project awarded to Ph.D. fellow Roer ‘Is traumatic experiences a risk factor for metabolic syndrome and type 2 diabetes mellitus?’ (project number 150632) and from the Southern and Eastern Norway Regional Health Authority through the research project awarded to Professor Abebe ‘Patterns and courses of somatic illness and the utilization of health services among patients with substance use disorders and/or mental disorders in Norway’ (project number 150901).en_US
dc.language.isoengen_US
dc.publisherBioMed Centralen_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/deed.no*
dc.subjectAlcohol use disorderen_US
dc.subjectCardiovascular diseasesen_US
dc.subjectCohort studyen_US
dc.subjectComorbidityen_US
dc.subjectDepressionen_US
dc.subjectDiabetes mellitusen_US
dc.subjectEpidemiologyen_US
dc.subjectMetabolic diseasesen_US
dc.subjectPosttraumatic stress disorderen_US
dc.subjectRegister dataen_US
dc.titleThe impact of PTSD on risk of cardiometabolic diseases: a national patient cohort study in Norwayen_US
dc.title.alternativeThe impact of PTSD on risk of cardiometabolic diseases: a national patient cohort study in Norwayen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.rights.holder© 2023. The Author(s). This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.en_US
dc.source.pagenumber9en_US
dc.source.volume23en_US
dc.source.journalBMC Psychiatryen_US
dc.source.issue1en_US
dc.identifier.doi10.1186/s12888-023-04866-x
dc.identifier.cristin2149002
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode2


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Attribution-NonCommercial-NoDerivatives 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Attribution-NonCommercial-NoDerivatives 4.0 Internasjonal